Clinical Trial

A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's

Study acronym: Eliminate
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The present study is a phase II/III prospective randomized trial designed to determine whether eliminating of post operative radiotherapy to regional lymphatics in pN0-N1oral cavity is associated with similar treatment outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-10.
Trial Details
NCT Number NCT07528495
Lead Sponsor All India Institute of Medical Sciences
Collaborators: All India Institute of Medical Sciences, Rishikesh, All India Institute of Medical Sciences, Raipur, Jawaharlal Institute of Postgraduate Medical Education & Research
Conditions Head and Neck Cancer
Enrollment 396 participants
Start Date 2024-04-03
Primary Completion 2027-12-30 (estimated)
Study Completion 2028-04-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-06